Tilray Brands Inc. closed 59.60% short of its 52-week high of $2.97, which the company reached on April 4th.

Tilray Medical, a division of (Nasdaq: TLRY; TSX: TLRY), proudly announces that its German subsidiary, Tilray Deutschland GmbH, has secured a tender to supply Luxembourg with its high-quality ...

Tilray hopes that with legalization, it could export medical marijuana to the U.S. and capitalize on its infused beverage ...

Canada’s largest cannabis retailer will take its talents into the German medical cannabis market by acquiring 51 per cent of ...

Analyst Robert Moskow of TD Cowen maintained a Buy rating on Tilray (TLRY – Research Report), with a price target of $1.50.Stay Ahead of the ...

Thank you for joining us for today's conference call to discuss Tilray Brands' financial results for the second quarter ended ...

New York hits $1B cannabis sales, Ukraine registers first medical product. Updates on DoorDash, Tilray, Agrify and more.

Cannabis company Tilray Brands (NASDAQ:TLRY) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 8.9% year ...

Tilray Brands' upcoming fiscal Q2 results are expected to show revenue growth. Check out why I think investors should avoid ...

Tilray topped Wall Street sales expectations Friday as the company continues beefing its beer business amid sluggish ...

The head of Tilray Brands Inc. says he was pleased with the company’s performance in its latest quarter despite tax ...

Medical, a division of Tilray Brands, announces that its German subsidiary, Tilray Deutschland GmbH, has secured a tender to ...